Therapeutic Clinical Nutrition Manufacturers and Market Growth

Who are the Therapeutic Clinical Nutrition Market Top Companies and What are Their Offerings?

What are the Major Recent Developments in the Therapeutic Clinical Nutrition Market?

• In May 2026, Celevida GLP+, which is a nutritional supplement, was launched by a joint venture between Dr. Reddy’s Laboratories Ltd. and Nestle India Ltd. This product will help in maintaining muscle mass and optimum nutrition intake in type 2 diabetes and obesity patients reciveing GLP-1/GIP therapy in India.
• In December 2025, two new advanced multivitamin supplements for men and women were launched by Rasayanam. These products will support metabolism, energy, immunity, and overall well-being to provide targeted, gender-specific multivitamins.

Therapeutic Clinical Nutrition Market Value Chain Analysis

R&D

• The R&D of therapeutic clinical nutrition focuses on the development of personalized medical foods and precision nutrition formulas.
• Key players: Abbott Nutrition, Danone, Nestle Health Science.

Clinical Trials and Regulatory Approvals

• The safety, manufacturing consistency, and clinical efficacy are evaluated in the clinical trials and regulatory approvals of the therapeutic clinical nutrition.
• Key players: Abbott Nutrition, Danone, Nestle Health Science.

Patient Support and Services

• Specialized home care nursing services, reimbursement assistance, and digital health monitoring apps are provided in the patient support and services of the therapeutic clinical nutrition therapy.
• Key players: Abbott Nutrition, Danone, Nestle Health Science.

Market Growth

The global therapeutic clinical nutrition market size was estimated at USD 61.84 billion in 2025 and is predicted to increase from USD 66.76 billion in 2026 to approximately USD 132.89 billion by 2035, expanding at a CAGR of 7.95% from 2026 to 2035.